Citation Impact
Citing Papers
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
2004 StandoutScience
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study
2012 Standout
Restless legs syndrome/Willis–Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria – history, rationale, description, and significance
2014 Standout
Hypoxia‐inducible factor pathway activation in restless legs syndrome patients
2011
Pathogenic implications of iron accumulation in multiple sclerosis
2011
Restless Legs Syndrome and Sleep Disturbance during Pregnancy: The Role of Folate and Iron
2001
The utility of toluidine blue application as a diagnostic aid in patients previously treated for upper oropharyngeal carcinoma
1997
Willis-Ekbom Disease Foundation Revised Consensus Statement on the Management of Restless Legs Syndrome
2013
Chemoprevention of squamous cell carcinoma of the head and neck
2007
TGF-β and cancer
1999
Diminished iron concentrations increase adenosine A2A receptor levels in mouse striatum and cultured human neuroblastoma cells
2008
Parkinson disease
2017 Standout
When gender matters: Restless legs syndrome. Report of the “RLS and woman” workshop endorsed by the European RLS Study Group
2011
Low body stores of iron and restless legs syndrome: a correctable cause of insomnia in adolescents and teenagers
2002
Restless Legs Syndrome
2008
Cancer Prevention With Natural Compounds
2010
Impact of restless legs syndrome and iron deficiency on attention-deficit/hyperactivity disorder in children
2007
A Randomized Controlled Trial of Oral versus Intravenous Iron in Chronic Kidney Disease
2006
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
2009 Standout
Exploring the Relationship Between Parkinson Disease and Restless Legs Syndrome
2002
Signal integration by JNK and p38 MAPK pathways in cancer development
2009 Standout
Restless legs syndrome: A sensorimotor disorder of sleep/ wake motor regulation
2002
AP-1: a double-edged sword in tumorigenesis
2003 Standout
TGF-β signaling in tumor suppression and cancer progression
2001 Standout
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
2009 Standout
The restless legs syndrome
2005
Head and neck cancer
2008 Standout
Oxidative stress and cellular pathologies in Parkinson’s disease
2017
Global epidemiology of oral and oropharyngeal cancer
2008 Standout
The role of iron in restless legs syndrome
2007
Randomized Phase III Trial of Low-dose Isotretinoin for Prevention of Second Primary Tumors in Stage I and II Head and Neck Cancer Patients
2006
Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat
2001
Effects of antioxidant supplements on cancer prevention: meta-analysis of randomized controlled trials
2009
The severity range of restless legs syndrome (RLS) and augmentation in a prospective patient cohort: Association with ferritin levels
2009
Transcranial ultrasound shows nigral hypoechogenicity in restless legs syndrome
2005
The molecular biology of head and neck cancer
2010 Standout
Long‐term course of restless legs syndrome in dialysis patients after kidney transplantation
2002
Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology
2003 Standout
Ectopic Expression of Nonliganded Retinoic Acid Receptor β Abrogates AP-1 Activity by Selective Degradation of c-Jun in Cervical Carcinoma Cells
2004 StandoutNobel
Glutamate neurotoxicity and diseases of the nervous system
1988 Standout
Mechanisms of brain injury after intracerebral haemorrhage
2005 Standout
A role of PIEZO1 in iron metabolism in mice and humans
2021 StandoutNobel
An Update on the Dopaminergic Treatment of Restless Legs Syndrome and Periodic Limb Movement Disorder
2004
The role of antioxidants in the chemistry of oxidative stress: A review
2015 Standout
Curcumin: The story so far
2005 Standout
Apigenin: A Promising Molecule for Cancer Prevention
2010 Standout
Ferritin for the clinician
2008
Randomized Phase III Intergroup Trial of Isotretinoin to Prevent Second Primary Tumors in Stage I Non-Small-Cell Lung Cancer
2001
Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?
2015 Standout
Novel agents and incremental advances in the treatment of head and neck cancer
2004
Restless Legs Syndrome
2001
Imaging iron stores in the brain using magnetic resonance imaging
2005
Lower molecular weight intravenous iron dextran for restless legs syndrome
2013
The promise of retinoids to fight against cancer
2001
Epidemiology of restless legs syndrome: A synthesis of the literature
2011
Restless Legs Syndrome
2004
Controversies and Challenges in Defining the Etiology and Pathophysiology of Restless Legs Syndrome
2006
MRI-determined regional brain iron concentrations in early- and late-onset restless legs syndrome
2006
Ferrous Sulfate Supplementation Causes Significant Gastrointestinal Side-Effects in Adults: A Systematic Review and Meta-Analysis
2015 Standout
Utility of toluidine blue in oral premalignant lesions and squamous cell carcinoma: Continuing research and implications for clinical practice
2007
Chemoprevention of Cancer
2004
Restless Legs Syndrome Prevalence and Impact
2005 Standout
Green tea catechin, epigallocatechin-3-gallate (EGCG): Mechanisms, perspectives and clinical applications
2011 Standout
Chemoprevention of oral leukoplakia with vitamin A and beta carotene: an assessment
1997
New hypotheses for the health-protective mechanisms of whole-grain cereals: what is beyond fibre?
2010 Standout
Non-motor features of Parkinson disease
2017 Standout
The role of iron in brain ageing and neurodegenerative disorders
2014 Standout
Differential expression of retinoic acid receptor beta (RARβ) and the AP-1 transcription factor in normal, premalignant and malignant human laryngeal tissues
2004
Iron Biology in Immune Function, Muscle Metabolism and Neuronal Functioning
2001
Drug discovery from medicinal plants
2005 Standout
Quantitation of chemopreventive synergism between (-)-epigallocatechin- 3-gallate and curcumin in normal, premalignant and malignant human oral epithelial cells
1998
CSF iron, ferritin and transferrin levels in restless legs syndrome
2005
Suppression of Retinoic Acid Receptor–β in Premalignant Oral Lesions and Its Up-Regulation by Isotretinoin
1995
Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals
2010 Standout
Brain iron uptake and homeostatic mechanisms: An overview
2003
CURCUMIN: THE INDIAN SOLID GOLD
2007 Standout
Oxidative stress and neurodegeneration: where are we now?
2006 Standout
Prevention of head and neck cancer: Current status and future prospects
2004
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
2006 Standout
Retinoids: present role and future potential
1999
Cancer in the elderly: is it preventable?
2004
Molecular genetic studies ofDMT1on 12q in French‐Canadian restless legs syndrome patients and families
2007
Selective Inhibition of Hypoxia-Inducible Factor (HIF) Prolyl-Hydroxylase 1 Mediates Neuroprotection against Normoxic Oxidative Death via HIF- and CREB-Independent Pathways
2009 StandoutNobel
Restless legs syndrome: Understanding its consequences and the need for better treatment
2010
Head and Neck Cancer
2001 Standout
Functional roles of transferrin in the brain
2011
European guidelines on management of restless legs syndrome: report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the European Sleep Research Society
2012
Luminescent Chemodosimeters for Bioimaging
2012 Standout
IRON STATUS AND NEURAL FUNCTIONING
2003
Toluidine blue: A review of its chemistry and clinical utility
2012 Standout
Anticancer potential of curcumin: preclinical and clinical studies.
2003 Standout
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
2012 Standout
Control of Sleep and Wakefulness
2012
Decreased transferrin receptor expression by neuromelanin cells in restless legs syndrome
2004
Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of Americaa
2012 Standout
Defining the phenotype of the restless legs syndrome (RLS) using age-of-symptom-onset
2000
Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression.
1997
About Sleep's Role in Memory
2013 Standout
Heme and Iron Metabolism: Role in Cerebral Hemorrhage
2003
Impact of Natural Products on Developing New Anti-Cancer Agents
2009 Standout
Perspectives for Cancer Prevention With Natural Compounds
2009
Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma
2007 Standout
Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome
2003
Oxidative Stress: A Key Modulator in Neurodegenerative Diseases
2019 Standout
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Metals in Neurobiology: Probing Their Chemistry and Biology with Molecular Imaging
2008 Standout
Restless legs syndrome and PD
2003
Works of C.J. Earley being referenced
Profile of altered brain iron acquisition in restless legs syndrome
2011
Iron deficiency alters expression of dopamine-related genes in the ventral midbrain in mice
2013
Prevention of Second Primary Tumors With Isotretinoin in Patients With Squamous Cell Carcinoma of the Head and Neck: Long-term Follow-up
1994
Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome
2000